{"id":"W1490550714","doi":"10.1002/cncr.28406","title":"Intravenous aflibercept in patients with platinum‐resistant, advanced ovarian cancer: Results of a randomized, double‐blind, phase 2, parallel‐arm study","year":2013,"lang":"en","type":"article","venue":"Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Aflibercept; Clinical endpoint; Internal medicine; Topotecan; Ovarian cancer; Cohort; Surgery; Randomized controlled trial; Phases of clinical research; Cancer; Progression-free survival; Clinical trial; Chemotherapy; Bevacizumab; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002509105,0.000370316,0.001408478,0.0002018808,0.00005975987,0.00002954004,0.0001370983,0.00009879582,0.001049033],"category_scores_gemma":[0.00004046855,0.0002572184,0.0001212937,0.0004614831,0.0001429528,0.0001743435,0.00003719691,0.0002279502,0.00001497668],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005164454,"about_ca_system_score_gemma":0.000398037,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01026765,"about_ca_topic_score_gemma":0.003031485,"domain_scores_codex":[0.9973711,0.0001035847,0.0009278358,0.0006257446,0.0005207405,0.0004509953],"domain_scores_gemma":[0.99825,0.0001360057,0.0004626071,0.0005622801,0.00036366,0.0002254202],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8485773,0.01122774,0.07800839,0.0001224535,0.001284571,0.00005607279,0.004401537,0.0006280197,0.00004606132,0.00007211901,0.0006373493,0.05493836],"study_design_scores_gemma":[0.8547121,0.003553733,0.1391974,0.0005736024,0.0005978227,7.856735e-7,0.0003593772,0.00004754605,0.000220253,0.00004064003,0.000425147,0.0002715724],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9873943,0.001257835,0.0000187291,0.0008245623,0.0002326546,0.008386215,0.0001848902,0.00003844504,0.001662421],"genre_scores_gemma":[0.9924745,0.0004759755,0.0004847633,0.0001795653,0.0001193593,0.005721431,0.00007982433,0.00005608182,0.0004085296],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06118904,"threshold_uncertainty_score":0.999988,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01861937080668284,"score_gpt":0.3044274961335927,"score_spread":0.2858081253269098,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}